Pharmacopeia (www.pharmacopeia.com) will assist WHO’s Special Program for Research and Training in Tropical Diseases (WHO/TDR) in its efforts to develop antimalarial agents.
The company will receive funding to conduct research on compounds identified through WHO/TDR’s drug-screening program involving a network of centers in developed and developing countries. The goal of this project is to identify new lead series with the potential to become novel malaria drug candidates.
